Persistent Asset Partners’s scPharmaceuticals SCPH Stock Holding History

Persistent Asset Partners’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,066	Closed	-$339K	–	438
2025 Q3	$339K	Sell	1,066 -57	-5%	-$292	0.23%	100
2025 Q2	$183K	Buy	+1,123	New	+$3.49K	0.14%	117

Persistent Asset Partners's SCPH Position: Q3 2025 in Review

Persistent Asset Partners sold out of scPharmaceuticals (SCPH) in Q3 2025, closing a stake of 50,107 shares — an estimated $257K sold.

Persistent Asset Partners first reported a position in SCPH in Q2 2025 and held it in 1 quarter. The position peaked at $191K in Q2 2025. 109 funds tracked by Wall St. Rank hold SCPH as of Q3 2025.

Persistent Asset Partners reported no remaining scPharmaceuticals position as of Q3 2025 after selling out during the quarter.
Persistent Asset Partners sold 50,107 scPharmaceuticals shares in Q3 2025, an estimated $257K.
Persistent Asset Partners first reported a position in scPharmaceuticals in Q2 2025 and held it in 1 quarter.
Persistent Asset Partners's scPharmaceuticals position peaked at $191K in Q2 2025.
109 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2025.

Based on Persistent Asset Partners's 13F filing for Q3 2025, filed 10 Nov 2025.